RESEARCH STUDIES BPC-157 Research Applications & Published Studies BPC-157 research spans more than two decades of published preclinical literature
Comparing lupus-relevant peptides This comparison table provides a quick reference for researchers evaluating which peptides to prioritize for lupus-related protocols
This complies with the FDA definition of sterile filtrated water
Monday + Thursday) Total per week: 45 mg Aggressive loading (severe / acute injuries): 5 mg per injection , twice weekly = 10 mg/week Conservative loading (prevention / budget): 2.5 mg per injection , twice weekly = 5 mg/week Duration: 46 weeks Total peptide for standard loading: approximately 4050 mg (standard) or 80 mg (aggressive) TB-500 maintenance phase dosage Standard maintenance dose: 22.5 mg once weekly Reduced maintenance: 2 mg every 2 weeks (for long-term joint support) Duration: 48 weeks after loading
Dopaminergic and serotonergic system modulation is documented in rodent neurological studies, with BPC-157 showing antidepressant-like behavioral effects in standardized animal paradigms
Signs suggesting adequate treatment include plateau in improvement for two or more weeks, significant resolution of primary concerns, and strong improvement maintained during previous breaks